Botelho, Monica C.Alves, HelenaJoachim, Richter2018-03-052018-03-052017-09-30Int J Cancer Manag. 2017;10(9). pii: e9430. doi: 10.5812/ijcm.9430. Epub 2017 Sep 302538-497X2538-4422http://hdl.handle.net/10400.18/5182Background: At present schistosomiasis is endemic in 78 countries, affecting more than 260 million people. Schistosomiasis haematobia alone affects more than 112 millions. Evidence Acquisition: We performed a computerized search of in PubMed database with keywords: Bladder Cancer Cost and Schistosomiasis Mass Treatment. Results: Bladder cancer is an important sequelae of this infection. In low-resource countries, where this disease is endemic, individuals inflicted with bladder cancer have very limited access to treatment and death is most probably certain. Conclusions: Mass treatment with praziquantel is an easy, safe, and inexpensive treatment that could save the lives of thousands and reduce the morbidity of millions.engSchistosomiasisBladderCancerMass TreatmentBladder CancerHalting Schistosoma haematobium - Associated Bladder Cancerjournal article10.5812/ijcm.9430.